KPP Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
KPP Advisory Services's PFE Position: Q2 2026 in Review
KPP Advisory Services reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $61.9K and leaving 15,236 shares worth $367K. The position accounts for 0.05% of the portfolio, ranked #272.
KPP Advisory Services first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $775K in Q3 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- KPP Advisory Services held 15,236 shares of Pfizer worth $367K as of Q2 2026.
- KPP Advisory Services sold 2,368 Pfizer shares in Q2 2026, an estimated $61.9K.
- Pfizer made up 0.05% of KPP Advisory Services's portfolio in Q2 2026, its #272 holding.
- KPP Advisory Services first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
- KPP Advisory Services's Pfizer position peaked at $775K in Q3 2023.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.